Last reviewed · How we verify
NCT04141566
Pseudo Continent Perineal Colostomy vs Permanent Left Iliac Colostomy After Abdominoperineal Resection for Ultra Low Rectal Adenocarcinoma
trial testing Perineal pseudocontinent colostomy in Rectal Neoplasms in 35 participants. Completed in 30 June 2020.
30 June 2020
Quick facts
| Lead sponsor | Moroccan Society of Surgery |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 35 |
| Start date | 1 January 2018 |
| Primary completion | 30 June 2020 |
| Estimated completion | 30 June 2020 |
| Sites | 1 location across Morocco |
Drugs / interventions tested
- Perineal pseudocontinent colostomy
- Permanent left iliac colostomy
Conditions studied
- Rectal Neoplasms — all drugs for Rectal Neoplasms →
- Colostomy Stoma — all drugs for Colostomy Stoma →
- Quality of Life — all drugs for Quality of Life →
Sponsor
Moroccan Society of Surgery
Who can join
18 and older, any sex, with Rectal Neoplasms or Colostomy Stoma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Aim of this study is to compare the cost-effectiveness and the quality of life in the 6 months following the surgery of a pseudo continent perineal colostomy (PCPC) and a permanent left iliac colostomy (PLIC) following an abdominoperineal resection (APR) for ultra low rectal cancer
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04141566
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Rectal Neoplasms
Currently open trials in the same condition.
- NCT07522294 — Optimization and Standardization of Single-Port Robotic Transanal Minimally Invasive Surgery for Rectal Tumor Excision · NA · active not recruiting
- NCT07154173 — Comprehensive Analysis of Gut Microbiota Signatures in Metastatic Colorectal Cancer · recruiting
- NCT06442215 — Selection of Surgical Technique in Rectal Cancer · recruiting
- NCT06017583 — Neoadjuvant Chemotherapy With PD-1 Inhibitors Combined With SIB-IMRT in the Treatment of Locally Advanced Rectal Cancer · Phase 3 · recruiting
- NCT05943444 — Comparison of Postoperative Anal Function Between Parks and Bacon Techniques in Low Rectal Cancer · NA · recruiting
Other Moroccan Society of Surgery trials
Trials by the same sponsor.
- NCT04607577 — Cross-cultural Adaptation and Validation in Moroccan Arabic Dialect "Darija" of the QoR-15 Postoperative Recovery Qualit · unknown
- NCT05494281 — Serratus Anterior Plane Block to Prevent Chronic Postoperative Pain in Breast Cancer · NA · unknown
- NCT04130568 — Translation and Adaptation of Learning Organisation Survey for French Speaking Countries · completed
- NCT04000802 — Evaluation of the Decision-making During Multidisciplinary Meetings for Digestive Cancers · completed
- NCT05286411 — Evaluation of the Implementation of a Quality Improvement Program Through Morbidity and Mortality Reviews · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04141566 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Moroccan Society of Surgery
- Last refreshed: 1 September 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04141566.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing